Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Amylin Hit Hardest By Bydureon Setback

Oct 20 2010

• By Lisa LaMotta

Related Content

Alkermes Unveils Bydureon Royalties And Its Own Long-acting Form Of Lilly's Zyprexa

Apr 26 2010

Amylin And Takeda Team Up In Obesity

Nov 03 2009

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window